IBgard is a medical food specially formulated for the daily dietary management of IBS. IBgard utilizes breakthrough science via SST® (Site-Specific Targeting). This SST technology provides the more distal delivery mentioned in the American College of Gastroenterology (ACG) IBS 2018 Monograph. SST technology delivers microspheres of peppermint oil (in a solid state), along with fiber and amino acids (from gelatin protein), predominantly in the small intestine, where it spreads out in a “broad brush” fashion for more distal delivery, i.e., delivery in the lower gut (small intestine) over a 3- to 4-hour period.1 The signature symptom of IBS is abdominal pain or discomfort, for which doctors struggle to find sufficient management options.*
In a landmark, randomized, multi-centered, double-blind, placebo-controlled trial, IBgard, taken daily and proactively, 30 to 90 minutes before meals, was shown to start working in as early as 24 hours.1 In this trial, IBgard showed good efficacy in managing abdominal pain, even “severe or unbearable pain.” IBS-M is a subtype of IBS that is estimated to comprise the majority of IBS sufferers2; there is no approved product for this community of patients. No heartburn or anal burning was seen with IBgard in this study.1,3 The study was peer-reviewed and published in distinguished medical journals in Feb. 2016 and Sep. 2017.1,3
In June 2018, the American College of Gastroenterology IBS Monograph endorsed peppermint oil for IBS but mentioned that conventional preparations are associated with causing heartburn.4 It mentioned that heartburn can be avoided with “more distal delivery.” IBgard’s SST technology provides more distal delivery.
IBgard, taken before meals, is designed to help with normalizing nutritional intake and to also reduce the nutrient absorption issues in IBS.
1Cash BD, Epstein MS, Shah SM. A Novel Delivery System of Peppermint Oil Is an Effective Therapy for Irritable Bowel Syndrome Symptoms. Dig Dis Sci. 2016;61(2):560-571. doi:10.1007/s10620-015-3858-7.
2Drossman DA, Morris CB, Schneck S, et al. International Survey of Patients with IBS: Symptom Features and their Severity, Health Status, Treatments, and Risk Taking to Achieve Clinical Benefit. J Clin Gastroenterol. 2009;43(6):541-550.
3Cash BD, Epstein MS, Shah S. Peppermint Oil with Site Specific Targeting is an Effective Therapy for Irritable Bowel Syndrome with Mixed Bowel Habits. Intern Med Rev. 2017;3(9):1-20.
4Ford AC, Moayyedi P, Chey WD, et al. American College of Gastroenterology Monograph on the Management of Irritable Bowel Syndrome. Am J Gastroenterol. 2018 June 27. doi:10.1038/s41395-018-0084-x.
‡Among gastroenterologists who recommended peppermint oil for IBS. Alpha ImpactRx ProVoice survey (September 2018).
Use under medical supervision